AKT1 and cancer: In the field of cancer, Gao et al. found that PCDH10 can directly participate in the negative regulation of the EGFR/Akt/β-Catenin signaling pathway, thereby inhibiting the occurrence and development of colorectal cancer (Jao et al., 2021).